Erratum to: Human equilibrative nucleoside transporter 1 level does not predict prognosis in pancreatic cancer patients treated with neoadjuvant chemoradiation including gemcitabine

Publisher： John Wiley & Sons Inc

E-ISSN： 1868-6982|19|6|723-723

ISSN： 1868-6974

Source： JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, Vol.19, Iss.6, 2012-11, pp. : 723-723

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Human equilibrative nucleoside transporter 1 level does not predict prognosis in pancreatic cancer patients treated with neoadjuvant chemoradiation including gemcitabine

By  

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, Vol. 19, Iss. 6, 2012-11 ,pp. : 717-722

John Wiley & Sons Inc

Access to resources Recommend Favorite

Human equilibrative nucleoside transporter 1 testing in pancreatic ductal adenocarcinoma: a comparison between murine and rabbit antibodies

By  

HISTOPATHOLOGY, Vol. 66, Iss. 3, 2015-02 ,pp. : 457-462

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pre‐treatment carbohydrate antigen 19‐9 does not predict the response to neoadjuvant therapy in patients with localized pancreatic cancer

By  

HPB, Vol. 17, Iss. 10, 2015-10 ,pp. : 942-952

John Wiley & Sons Inc

Access to resources Recommend Favorite

Can Dynamic MR Imaging Predict Response in Patients with Rectal Cancer Undergoing Cetuximab-Based Neoadjuvant Chemoradiation?

By  

Oncology Research and Treatment, Vol. 32, Iss. 3, 2009-02 ,pp. : 86-93

Karger

Access to resources Recommend Favorite

Does the Extent of Lymphadenectomy Have Impact on the Prognosis of Patients with Pancreatic Cancer?

By  

Oncology Research and Treatment, Vol. 25, Iss. 1, 2002-03 ,pp. : 69-71

Karger

Access to resources Recommend Favorite